Cargando…
Immunogenicity and Protective Effect of a Virus-Like Particle Containing the SAG1 Antigen of Toxoplasma gondii as a Potential Vaccine Candidate for Toxoplasmosis
This study was carried out to evaluate the vaccination effect of a virus-like particle (VLP) including the surface antigen 1 (SAG1) of Toxoplasma gondii as a potential vaccine for toxoplasmosis. The SAG1 virus-like particles (SAG1-VLPs) were expressed by Sf9 cells, and their expression was confirmed...
Autores principales: | Choi, Won Hyung, Park, Ji Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235809/ https://www.ncbi.nlm.nih.gov/pubmed/32325746 http://dx.doi.org/10.3390/biomedicines8040091 |
Ejemplares similares
-
Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
por: Guo, Jingjing, et al.
Publicado: (2019) -
Vaccination against Murine Toxoplasmosis Using Recombinant Toxoplasma gondii SAG3 Antigen Alone or in Combination with Quil A
por: Lee, Young-Ha, et al.
Publicado: (2007) -
Targeted Delivery of Toxoplasma gondii Antigens to Dendritic Cells Promote Immunogenicity and Protective Efficiency against Toxoplasmosis
por: Lakhrif, Zineb, et al.
Publicado: (2018) -
Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii
por: Wang, Yanhua, et al.
Publicado: (2014) -
Evaluation of Immunogenic Effect of Toxoplasma gondii Recombinant SAG-1 Antigen with Propranolol as Adjuvant in BALB/c Mice
por: Abasi, Esmaeil, et al.
Publicado: (2019)